Brangista Inc.
Brangista Inc. (6176.T) Financial Performance & Income Statement Overview
Review Brangista Inc. (6176.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Brangista Inc. (6176.T) Income Statement & Financial Overview
Analyze Brangista Inc.’s 6176.T earnings with segmented quarterly and yearly financial statement figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $1.37B | $1.23B | $1.32B | $1.15B |
Cost of Revenue | $405.53M | $364.00M | $346.00M | $273.00M |
Gross Profit | $961.02M | $862.00M | $978.00M | $872.00M |
Gross Profit Ratio | $0.70 | $0.70 | $0.74 | $0.76 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $660.87M | $639.00M | $677.00M | $687.00M |
Operating Expenses | $660.87M | $639.00M | $689.00M | $687.00M |
Total Costs & Expenses | $1.07B | $1.003B | $1.03B | $960.00M |
Interest Income | $697000.00 | $0.00 | $0.00 | $16000.00 |
Interest Expense | $1.07M | $0.00 | $0.00 | $894000.00 |
Depreciation & Amortization | $9.63M | $9.00M | $9.00M | $8.00M |
EBITDA | $310.25M | $232.00M | $295.46M | $193.00M |
EBITDA Ratio | $0.23 | $0.19 | $0.22 | $0.17 |
Operating Income | $300.15M | $223.00M | $289.00M | $185.00M |
Operating Income Ratio | $0.22 | $0.18 | $0.22 | $0.16 |
Other Income/Expenses (Net) | -$596000.00 | -$2.00M | -$6.00M | -$1.00M |
Income Before Tax | $299.56M | $221.00M | $283.00M | $184.00M |
Income Before Tax Ratio | $0.22 | $0.18 | $0.21 | $0.16 |
Income Tax Expense | $101.56M | $78.00M | $78.00M | $72.00M |
Net Income | $182.76M | $135.00M | $191.00M | $110.00M |
Net Income Ratio | $0.13 | $0.11 | $0.14 | $0.10 |
EPS | $13.70 | $9.98 | $14.13 | $8.14 |
Diluted EPS | $13.70 | $9.98 | $14.13 | $8.14 |
Weighted Avg Shares Outstanding | $13.34M | $13.52M | $13.52M | $13.52M |
Weighted Avg Shares Outstanding (Diluted) | $13.34M | $13.52M | $13.52M | $13.52M |
The company's financials show resilient growth, with revenue advancing from $1.15B in Q3 2024 to $1.37B in Q2 2025. Gross profit remained healthy with margins at 70% in Q2 2025 compared to 76% in Q3 2024. Operating income hit $300.15M last quarter, sustaining a consistent 22% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $310.25M. Net income rose to $182.76M, while earnings per share reached $13.70. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan